National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

Found 11,184 cases where Vaccine is MENB

Government Disclaimer on use of this data



Case Details

This is page 45 out of 1,119

Result pages: prev   36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54   next


VAERS ID: 628703 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Male  
Location: New York  
Vaccinated:2016-03-21
Onset:2016-03-21
   Days after vaccination:0
Submitted: 2016-03-23
   Days after onset:2
Entered: 2016-03-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) / GLAXOSMITHKLINE BIOLOGICALS 3343R / 1 LA / IM
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH M37314 / 1 LA / IM

Administered by: Unknown       Purchased by: Public
Symptoms: Chills, Dizziness, Headache, Pain, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Vestibular disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Adderall XR 20MG (1 PO daily)
Current Illness: No
Preexisting Conditions: ADHD
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Chills, bodyache, fever, dizzy, headache.


VAERS ID: 628710 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: New York  
Vaccinated:2016-03-21
Onset:2016-03-21
   Days after vaccination:0
Submitted: 2016-03-23
   Days after onset:2
Entered: 2016-03-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH M37314 / 1 LA / IM

Administered by: Private       Purchased by: Public
Symptoms: Chills, Muscle spasms, Tremor
SMQs:, Neuroleptic malignant syndrome (broad), Dystonia (broad), Parkinson-like events (broad), Noninfectious encephalopathy/delirium (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Lantus 100Unit/ml, Proair HFA 108mcg, Simvastatin 10MG, Vitamin D-3 1000 Unit, Calcium 600 and Vit D3 600-800MG
Current Illness: No
Preexisting Conditions: Type 1 Diabetes Mellitus, Asthma, Mixed Hyperlipidemia
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Chills, leg cramps, shaky.


VAERS ID: 628777 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: Michigan  
Vaccinated:2016-03-07
Onset:2016-03-07
   Days after vaccination:0
Submitted: 2016-03-23
   Days after onset:15
Entered: 2016-03-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 149001 / UNK RL / SYR

Administered by: Other       Purchased by: Other
Symptoms: Injection site pain
SMQs:, Extravasation events (injections, infusions and implants) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2016037775

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a 17-year-old female patient who received BEXSERO (batch number 149001, expiry date unknown). On 7th March 2016, the patient received BEXSERO .5 ml. On 7th March 2016, less than a day after receiving BEXSERO, the patient experienced injection site pain. The patient was treated with MOTRIN. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site pain to be related to BEXSERO. Additional details were received as follows: This case was previously reported to a doctor. This case was reported by a certified medical assistant. The patient experienced pain at the injection site, for over 8 days. The patient had been taking over the counter MOTRIN to treat the pain. The reporter did not know the expiration date of the product. The reporter provided the 15th August 2015 as the revision date for the product.


VAERS ID: 628969 (history)  
Form: Version 1.0  
Age: 20.0  
Sex: Female  
Location: California  
Vaccinated:2015-10-16
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2016-03-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUZONE) / SANOFI PASTEUR U5319AA / UNK LA / IM
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH U28923 / 1 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Electromyogram abnormal, Guillain-Barre syndrome, Injection site rash, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Hypersensitivity (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: EMG - proximal muscle membrane irritabilities 1/20/16
CDC Split Type:

Write-up: Rash at injection site after 2 days after vaccine and then 5 wks later, apx 11/21/15 started with thigh weakness, neuro dx''ed as variant Guillain-Barre, resolved March 2016.


VAERS ID: 629007 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Arizona  
Vaccinated:2015-12-16
Onset:0000-00-00
Submitted: 2016-03-23
Entered: 2016-03-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK AR / UN
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / 1 AR / IM

Administered by: Other       Purchased by: Other
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site warmth, Myalgia
SMQs:, Rhabdomyolysis/myopathy (broad), Extravasation events (injections, infusions and implants) (broad), Eosinophilic pneumonia (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2016037781

Write-up: This case was reported by a consumer via call center representative and described the occurrence of injection site lump in a 16-year-old female patient who received BEXSERO. Concomitant products included Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. On 16th December 2015, the patient received the 1st dose of BEXSERO (intramuscular). On an unknown date, an unknown time after receiving BEXSERO, the patient experienced injection site lump and injection site warmth. On an unknown date, the outcome of the injection site lump and injection site warmth were unknown. It was unknown if the reporter considered the injection site lump and injection site warmth to be related to BEXSERO. Additional details were received as follows: The patient received the 1st dose in the series of BEXSERO. She also received a meningococcal vaccine on the same day (she believed it might have been brand name MENVEO, but was unsure). The 2 vaccines were administered in different arms. The patient developed a golf-ball sized lump at the site of the BEXSERO vaccine. The lump was red, warm to the touch, and sore for 1 month. The muscle soreness was severe enough to prevent the patient from driving. The patient attempted applying heat and ice, but the pain did not resolve. The patient also took over-the-counter pain medications to relieve the pain. When the patient presented to the clinic for the second BEXSERO injection, the lump had decreased in size, but was still present at the site of the previous injection. The patient''s mother requested that the second BEXSERO injection be administered slightly lower on the muscle and the patient did not have an adverse reaction to the second BEXSERO injection.


VAERS ID: 629040 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: Michigan  
Vaccinated:2016-03-07
Onset:0000-00-00
Submitted: 2016-03-23
Entered: 2016-03-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 149001 / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Pain in extremity
SMQs:, Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2016GSK038898

Write-up: This case was reported by a other health professional and described the occurrence of pain in a 17-year-old female patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced pain in thigh. On an unknown date, the outcome of the pain in thigh was recovered/resolved. It was unknown if the reporter considered the pain in thigh to be related to BEXSERO. Additional details provided were as follows: The pain in thigh lasted for 8 days.


VAERS ID: 629103 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: New Mexico  
Vaccinated:2016-02-15
Onset:2016-02-17
   Days after vaccination:2
Submitted: 2016-03-24
   Days after onset:35
Entered: 2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV9: HPV (GARDASIL 9) / MERCK & CO. INC. L045711 / 3 LA / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 151301D / 1 RA / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U5180AA / 2 RA / IM

Administered by: Public       Purchased by: Public
Symptoms: Injection site rash
SMQs:, Hypersensitivity (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: None
CDC Split Type:

Write-up: Localized rash at injection site (right deltoid area).


VAERS ID: 629126 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:2016-03-10
Onset:2016-03-10
   Days after vaccination:0
Submitted: 2016-03-24
   Days after onset:13
Entered: 2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Guillain-Barre syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


VAERS ID: 629289 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: D.C.  
Vaccinated:2016-03-22
Onset:2016-03-22
   Days after vaccination:0
Submitted: 2016-03-24
   Days after onset:2
Entered: 2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH M37315 / 1 LA / UN

Administered by: Private       Purchased by: Unknown
Symptoms: Chills, Fatigue, Headache, Nausea
SMQs:, Acute pancreatitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: ADHD; Depresssion
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: The evening after vaccine, pt started with fatigue, chills, HA, and nausea.


VAERS ID: 629229 (history)  
Form: Version 1.0  
Age: 50.0  
Sex: Male  
Location: California  
Vaccinated:2016-03-22
Onset:2016-03-22
   Days after vaccination:0
Submitted: 2016-03-25
   Days after onset:3
Entered: 2016-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 146101A / 2 LA / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS M15053 / 1 RA / IM

Administered by: Private       Purchased by: Private
Symptoms: Bradyphrenia, Fatigue, Immediate post-injection reaction, Impaired work ability, Injection site hypoaesthesia, Injection site pain, Injection site paraesthesia, Movement disorder, Neck pain
SMQs:, Akathisia (broad), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Psychosis and psychotic disorders (broad), Noninfectious encephalopathy/delirium (broad), Extravasation events (injections, infusions and implants) (broad), Hypersensitivity (narrow), Arthritis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Ergocalciferol, Vit D2, (VITAMIN D2) 50,000 unit Oral Cap Take 1 capsule orally every week for a total of 6 months then take over the counter Vitamin D 1000 units daily 6 3; Pantoprazole (PROTONIX) 40 mg Oral TBEC DR Tab Take 1 tablet or
Current Illness: No
Preexisting Conditions: Allergies/sensitivities: azithromycin, hydrocodone, oxycodone, ibuprofen, nitrofurantoin, Levitra
Allergies:
Diagnostic Lab Data: Pending
CDC Split Type:

Write-up: Patient with left side MEN-B (BEXSERO) (Meningococcal B) OMV given, right side MEN-ACYW (MENVEO) (meningococcal oligosaccharide ACYW-135). 1 month ago, Men-B (Bexsero given with neck pain). Severe pain on injection radiating with numb/tingling on right side immediately. Then severe fatigue, slowness in thought and movement, at least 3 days, still having symptoms - could not work.


Result pages: prev   36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=45&VAX=MENB


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166